ORGANIC
LETTERS
2002
Vol. 4, No. 6
885-888
A Formal Total Synthesis of
(±)-Cephalotaxine Using Sequential
N-Acyliminium Ion Reactions
Yuji Koseki, Hiroto Sato, Yumi Watanabe, and Tatsuo Nagasaka*
Tokyo UniVersity of Pharmacy and Life Science, School of Pharmacy,
1432-1 Horinouchi, Hachiouji, Tokyo 192-0392, Japan
Received November 24, 2001
ABSTRACT
Novel synthesis of cephalotaxine 1 based on tertiary N-acyliminium ion chemistry starting from alkynylamide 2 was achieved. The key steps
include the preparation of pyrroloisoquinoline 4 from alkynylamide 2, the ring expansion of pyrroloisoquinoline 4 to pyrrolobenzazepine 12,
and the construction of cyclopentapyrrolobenzazepine ring system 6, all of which are derived from N-acyliminium ion intermediates.
Cephalotaxine 1, a representative Cephalotaxus alkaloid,1
possesses the unique structure of a pentacyclic ring system
with a spiro-fused five-membered ring. Because of its unique
structural features and the antileukemic activity of its
2-alkylhydroxysuccinates such as harringtonine 1a,2,3 many
have reported4 about the total synthesis of cephalotaxine 1.
However, it is known that cephalotaxine itself displays no
significant antileukemic activity.
such as lennoxamine and chilenine, utilizing the ring-
expansion reaction of isoindoloisoquinoline to isoindolo-
benzazepine has also been reported.6 The utility of these
methods via N-acyliminium ion reactions7 directed us to the
(2) For reviews, see: (a) Huang, L.; Xue, Z. In The Alkaloids; Brossi,
A., Ed.; Academic Press: New York, 1984; Vol. 23, p 157. (b) Hudlicky,
T.; Kwart, L. D.; Reed, J. W. In Alkaloids; Pelletier, S. W., Ed.; John Wiley
and Sons: New York, 1987; Vol. 5, p 639. (c) Miah, M. A. J.; Hudlicky,
T.; Reed, J. W. In The Alkaloids; Cordell, G. A., Ed.; Academic Press:
New York, 1998; Vol. 51, p 199. (d) Smith, C. R., Jr.; Mikolajczak, K. L.;
Powell, R. G. In Anticancer Agents Based on Natural Product Models;
Cassady, J. M., Douros, J. D., Eds.; Academic Press: New York, 1980; p
391.
(3) For an isolation of new alkaloids, cephalezomines, see: Morita, H.;
Arisaka, M.; Yoshida, N.; Kobayashi, J. Tetrahedron 2000, 56, 2929.
(4) For recent total synthesis of 1, see: (a) Ikeda, M.; El Bialy, S. A.
A.; Hirose, K.; Kotake, M.; Sato, T.; Bayomi, S. M. M.; Shehata, I. A.;
Abdelal, A. M.; Gad, L. M.; Yakura, T. Chem. Pharm. Bull. 1999, 47,
983. (b) Tietze, L. F.; Schirok, H. J. Am. Chem. Soc. 1999, 121, 10264 and
references therein.
(5) (a) Koseki, Y.; Kusano, S.; Nagasaka, T. Tetrahedron Lett. 1998,
39, 3517. (b) Koseki, Y.; Kusano, S.; Ichi, D.; Yoshida, K.; Nagasaka, T.
Tetrahedron 2000, 56, 8855.
(6) Koseki, Y.; Kusano, S.; Sakata, H.; Nagasaka, T. Tetrahedron Lett.
1999, 40, 2169.
(7) For reviews, see: (a) Speckamp, W. N.; Moolenaar, M. J. Tetrahedron
2000, 56, 3817. (b) Hiemstra, H.; Speckamp, W. N. In ComprehensiVe
Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: Oxford, 1991;
Vol. 2, p 1047. (c) Speckamp, W. N.; Hiemstra, H. Tetrahedron 1985, 41,
4367.
In our laboratory, the alkylidenelactams obtained by the
AgOTf-(TMS)2NLi-catalyzed cyclization of alkynylamides
have been converted into N-acyliminium ion precursors for
the synthesis of 5-substituted 2-pyrrolidinone derivatives.5
Furthermore, the synthesis of isoindolobenzazepine alkaloids,
(1) For a first isolation of 1, see: Paudler, W. W.; Kerley, G. I.; McKay,
J. J. Org. Chem. 1963, 28, 2194.
10.1021/ol017114f CCC: $22.00 © 2002 American Chemical Society
Published on Web 02/22/2002